Key result
Quantitative and non-proton MRI techniques, such as 23Na MRI, provide deep insights into muscle pathophysiology and serve as valuable biomarkers for diagnosing and monitoring muscle diseases.
Why the study?
Neuromuscular imaging is gaining clinical relevance in diagnosing and monitoring inherited and acquired muscle diseases, and advanced quantitative MRI techniques provide deeper insights into muscle pathophysiology.
Advanced quantitative MRI techniques, particularly non-proton imaging like 23Na MRI, offer valuable insights into muscle pathophysiology and hold promise as diagnostic and monitoring biomarkers in neuromuscular diseases.
Answers are grounded in this paper and cite their sources.
Whole-body MRI may refine pattern-based diagnosis in muscle diseases; leaves open its validation as a standardized trial endpoint.
The role of neuromuscular imaging in the diagnosis of inherited and acquired muscle diseases has gained clinical relevance. In particular, magnetic resonance imaging (MRI), especially whole-body applications, is increasingly being used for the diagnosis and monitoring of disease progression. In addition, they are considered as a powerful outcome measure in clinical trials. Because many muscle diseases have a distinct muscle involvement pattern, whole-body imaging can be of diagnostic value by identifying this pattern and thus narrowing the differential diagnosis and supporting the clinical diagnosis. In addition, more advanced MRI applications including non-proton MRI, diffusion tensor imaging, perfusion MRI, T2 mapping, and magnetic resonance spectroscopy provide deeper insights into muscle pathophysiology beyond the mere detection of fatty degeneration and/or muscle edema. In this review article, we present and discuss recent data on these quantitative MRI techniques in muscle diseases, with a particular focus on non-proton imaging techniques.
No takes yet. Share an insight, caveat, or question.
Weber et al. (2020) conducted a review in Muscle diseases (myopathies, muscular channelopathies, muscular dystrophies). Quantitative MRI and non-proton MRI (e.g., 23Na MRI) was evaluated. Quantitative and non-proton MRI techniques, such as 23Na MRI, provide deep insights into muscle pathophysiology and serve as valuable biomarkers for diagnosing and monitoring muscle diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: